Download PDF
Semin Respir Crit Care Med 2002; 23(6): 505-512
DOI: 10.1055/s-2002-36515
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Neuromuscular Sarcoidosis

Alvin Teirstein
  • Mt. Sinai Medical Center, New York, New York
Further Information

Publication History

Publication Date:
07 January 2003 (online)

    Permissions and Reprints

ABSTRACT

Neuromuscular sarcoidosis is recognized with increasing frequency. Although reported to occur in only 5% of patients with sarcoidosis, major centers are reporting up to 20% neuromuscular involvement. While the majority of patients with neurologic involvement present with 7th nerve palsy, the reported frequency of sarcoidosis of the brain, meninges, spinal cord, and muscles is rising.

The diagnosis of neuromuscular sarcoidosis is usually accepted when a patient with previous biopsy-proven sarcoidosis presents with a compatible neurologic syndrome. In addition to cranial nerve abnormalities, these syndromes include leptomeningitis, seizures, mass lesions of brain and spinal cord, pituitary dysfunction, and neuropathies. Occasionally, the typical intrathoracic, ocular, cutaneous and lymph node presentations of sarcoidosis are not present or are unrecognized and the diagnosis is established by biopsy of neuromuscular tissue. Biopsy exhibiting granulomas is not specific and requires absence of evidence of known granulomagenic agents plus presence of multiorgan disease. An isolated granuloma in neural tissue without other organ involvement is not diagnostic of sarcoidosis.

Treatment of neuromuscular sarcoidosis is usually prolonged. Facial palsy often improves spontaneously. Prednisone is still the drug of choice. Most authorities agree that 30 to 40 mg qd is sufficient with concomitant azathioprine or cyclophosphamide.

KEYWORD

Neuromuscular - sarcoidosis - diagnosis - treatment

REFERENCES

  • 1 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases.  Ann Intern Med . 1977;  87 336-345
    CrossrefPubMedGoogle Scholar
  • 2 Stern B J, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations.  Arch Neurol . 1985;  42 909-917
    CrossrefPubMedGoogle Scholar
  • 3 Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients.  Acta Neurol Scand . 1986;  73 283-290
    PubMedGoogle Scholar
  • 4 Chapelon C, Ziza J M, Piette J C. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases.  Medicine . 1990;  69 261-276
    PubMedGoogle Scholar
  • 5 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
    CrossrefPubMedGoogle Scholar
  • 6 Ricker W, Clark M. Sarcoidosis: a clinicopathological review of three hundred cases, including twenty-two autopsies.  Am J Clin Pathol . 1949;  19 725-749
    CrossrefPubMedGoogle Scholar
  • 7 Manz H J. Pathobiology of neurosarcoidosis and clinicopathologic correlation.  Can J Neurol Sci . 1983;  10 50-55
    PubMedGoogle Scholar
  • 8 Urich H. Neurosarcoidosis or granulomatous angiitis: a problem of definition.  Mt Sinai J Med . 1977;  44 718-725
    PubMedGoogle Scholar
  • 9 Jaster J H, Dohan Jr C F, Bertorini T E. Solitary spinal cord sarcoidosis without other manifestations of systemic sarcoidosis.  Clin Imag . 1997;  21 17-22
    PubMedGoogle Scholar
  • 10 Sommer N, Weller M, Petersen D, Wietholter H, Dichgans J. Neurosarcoidosis without systemic sarcoidosis.  Eur Arch Psychiatry Clin Neurosci . 1991;  240 334-338
    PubMedGoogle Scholar
  • 11 Mayer S A, Yim G K, Onesti S T, Lynch T, Faust P L, Marder K. Biopsy-proven isolated sarcoid meningitis: case report.  J Neurosurg . 1993;  78 994-996
    CrossrefPubMedGoogle Scholar
  • 12 Lee S C, Spencer J, Rumberg J, Dickson D W. Isolated central nervous system granulomatosis resembling sarcoidosis.  J Neurol . 1989;  236 356-358
    PubMedGoogle Scholar
  • 13 James D G. Differential diagnosis of facial nerve palsey.  Sarcoidosis Vasc Diff Lung Dis . 1997;  14 115-120
    PubMedGoogle Scholar
  • 14 Nowak D A, Widenka D C. Neurosarcoidosis: a review of its intracranial manifestations.  J Neurol . 2001;  248 363-372
    CrossrefPubMedGoogle Scholar
  • 15 Martin B, Riskind P N. Neurologic manifestations of hypothalamic disease.  Prog Brain Res . 1992;  931 31-40
    PubMedGoogle Scholar
  • 16 Bullmann C, Faust M, Hoffmann A. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis.  Eur J Endocrinol . 2000;  142 365-372
    CrossrefPubMedGoogle Scholar
  • 17 Levivier M, Brotchi J, Baleriaux D, Pirotte B, Flament-Durand J. Sarcoidosis presenting as an isolated intramedullary tumor.  Neurosurgery . 1991;  29 271-276
    PubMedGoogle Scholar
  • 18 Veres L, Utz J B, Houser D W. Sarcoidosis presenting as a central nervous system mass lesion.  Chest . 1997;  111 518-521
    PubMedGoogle Scholar
  • 19 Mackowiak-Cordoliani M A, De Seze J, Stojkovic T, Ferriby Q, Ingrand D, Vermersch P. Sarcoidosis and progressive multifocal leukoencephalopathy.  Rev Neurol . 2001;  157 547-550
    PubMedGoogle Scholar
  • 20 Campbell J N, Black P, Ostrow P T. Sarcoid of the cauda equina: case report.  J Neurosurg . 1977;  47 109-112
    PubMedGoogle Scholar
  • 21 Junger S S, Stern B J, Levine S R, Sipos E, Marti-Masso J F. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics.  Neurology . 1993;  43 333-337
    CrossrefPubMedGoogle Scholar
  • 22 Vinas F C, Rengachary S, Kupsky W J. Spinal cord sarcoidosis: a diagnostic dilemma.  Neurol Res . 2001;  23 347-352
    CrossrefPubMedGoogle Scholar
  • 23 Longcope W T, Freiman D. Study of sarcoidosis, based on combined investigations of 160 cases, including 30 autopsies.  Medicine . 1952;  31 1-132
    CrossrefPubMedGoogle Scholar
  • 24 Galassi G, Gibertoni G G, Mancini A. Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases.  Eur Neurol . 1984;  23 459-465
    PubMedGoogle Scholar
  • 25 Gainsborough N, Hall S M, Hughes R A, Leibowitz S. Sarcoid neuropathy.  J Neurol . 1991;  238 177-180
    CrossrefPubMedGoogle Scholar
  • 26 Zuniga G, Ropper A H, Frank J. Sarcoid peripheral neuropathy.  Neurology . 1991;  41 1558-1561
    CrossrefPubMedGoogle Scholar
  • 27 Scott T S, Brillman J, Gross J A. Sarcoidosis of the peripheral nervous system.  Neurol Res . 1993;  15 389-390
    PubMedGoogle Scholar
  • 28 Wolfe S M, Pinals R S, Aelion J A, Goodman R E. Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature.  Semen Arthritis Rheum . 1987;  16 300-306
    PubMedGoogle Scholar
  • 29 Mozaffar T, Lopate G, Pestronk A. Clinical correlates of granulomas in muscle.  J Neurol . 1998;  245 519-524
    CrossrefPubMedGoogle Scholar
  • 30 Prayson R A. Granulomatous myositis: clincopathologic study of 12 cases.  Am J Clin Pathol . 1999;  112 63-68
    PubMedGoogle Scholar
  • 31 Silverstein A, Siltzbach L E. Muscle involvement in sarcoidosis.  Arch Neurol . 1969;  21 235-241
    PubMedGoogle Scholar
  • 32 Jamal M N, Cilursu A M, Hoffman E L. Sarcoidosis presenting as acute myositis: report and review of the literature.  J Rheumatol . 1988;  15 1868-1871
    PubMedGoogle Scholar
  • 33 Ost D, Yeldandi A, Cugell D. Acute sarcoid myositis with respiratory muscle involvement.  Chest . 1995;  107 879-882
    PubMedGoogle Scholar
  • 34 Sohn H S, Kim E N, Park J M, Chung Y A. Muscular sarcoidosis: Ga 67 scintigraphy and magnetic resonance imaging.  Clin Nucl Med . 2001;  26 29-32
    PubMedGoogle Scholar
  • 35 Otake S. Sarcoidosis involving the skeletal muscle: imaging findings and relative value of imaging procedures.  Am J Roentgenol . 1994;  162 369-375
    PubMedGoogle Scholar
  • 36 Oksanan V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis.  Sarcoidosis . 1987;  4 105-110
    PubMedGoogle Scholar
  • 37 Stern B J, Griffin D E, Luke R A, Krumholz, Johns C T. Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations.  Neurology . 1987;  37 878-881
    CrossrefPubMedGoogle Scholar
  • 38 Lexa F J, Grossman R I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.  Am J Neuroradiol . 1994;  15 973-982
    PubMedGoogle Scholar
  • 39 Christoforidis G A, Spickler E M, Recio M V, Mehta B M. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment.  Am J Neuroradiol . 1999;  20 655-669
    PubMedGoogle Scholar
  • 40 Pickuth D, Spielmann R P, Heywang-Kobrunner S H. Role of radiology in the diagnosis of neurosarcoidosis.  Eur Radiol . 2000;  10 941-944
    CrossrefPubMedGoogle Scholar
  • 41 Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurosarcoidosis.  Arch Int Med . 1997;  157 1864-1868
    CrossrefPubMedGoogle Scholar
  • 42 Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisone regimen.  Eur Respir J . 1999;  93 498-506
    PubMedGoogle Scholar
  • 43 Lewis S J, Ainslie G M, Bateman E D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 87-92
    PubMedGoogle Scholar
  • 44 Jones E, Callen J P. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidosis.  J Am Acad Dermatol . 1990;  23 487-489
    CrossrefPubMedGoogle Scholar
  • 45 Wallace D J. The use of chloroquine and hydroxychloroquine for noninfectious conditions other than arthritis or lupus: a critical review.  Lupus . 1996;  1 (suppl 5) S59-S64
    PubMedGoogle Scholar
  • 46 Stern B J, Schonfeld S A, Sewell C, Krumholz A, Scott P, Belendiuk G. Treatment of neurosarcoidosis with cyclosporine.  Arch Neurol . 1992;  49 1065-1072
    PubMedGoogle Scholar
  • 47 Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.  J Am Acad Dermatol . 1995;  32 866-869
    CrossrefPubMedGoogle Scholar
  • 48 Lee J B, Koblenzer P S. Disfiguring cutaneous manifestations of sarcoidosis treated with thalidomide: a case report.  J Am Acad Dermatol . 1998;  39 835-838
    PubMedGoogle Scholar
  • 49 Oliver S J, Kikuchi T, Krueger J G, Kaplan G. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.  Clin Immunol . 2002;  102 225-236
    CrossrefPubMedGoogle Scholar
  • 50 Kataria Y P. Chlorambucil in sarcoidosis.  Chest . 1980;  78 36-43
    CrossrefPubMedGoogle Scholar
  • 51 Israel H L, McComb B L. Chlorambicil treatment of sarcoidosis.  Sarcoidosis . 1991;  8 35-41
    PubMedGoogle Scholar
  • 52 Baughman R P, Lower E E. Infliximab for refractory sarcoidosis.  Sarcoidosis Vasc Diff Lung Dis . 2001;  18 70-74
    PubMedGoogle Scholar
  • 53 Yee A M, Pochapin M D. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.  Ann Int Med . 2001;  135 27-31
    CrossrefPubMedGoogle Scholar
  • 54 Sharma O P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.  Arch Neurol . 1998;  55 1248-1254
    CrossrefPubMedGoogle Scholar
  • 55 Agbogu B N, Stern B J, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis.  Arch Neurol . 1995;  52 875-879
    CrossrefPubMedGoogle Scholar
  • 56 Bejar J M, Kerby G R, Ziegler D K, Festoff B W. Treatment of central nervous system sarcoidosis with radiotherapy.  Ann Neurol . 1985;  18 258-260
    CrossrefPubMedGoogle Scholar
  • 57 Kang S, Suh J H. Radiation therapy for neurosarcoidosis: report of three cases from a single institution.  Radiat Oncol Investig . 1999;  7 309-312
    CrossrefPubMedGoogle Scholar
  • 58 Luke R A, Stern B J, Krumholz A, Johns C J. Neurosarcoidosis: the long-term clinical course.  Neurology . 1987;  37 461-463
    PubMedGoogle Scholar
  • 59 Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations.  Arch Pathol Lab Med . 1995;  119 167-172
    PubMedGoogle Scholar
  • 60 Baughman R P. Methotrexate for sarcoidosis.  Sarcoidosis Vasc Diff Lung Dis . 1998;  15 147-149
    PubMedGoogle Scholar